Literature DB >> 7823640

Predicting inpatient costs with admitting clinical data.

W M Tierney1, J F Fitzgerald, M E Miller, M K James, C J McDonald.   

Abstract

Hospital cost-containment programs should themselves be cost-effective, targeting high-cost physicians (which requires adjusting for case mix) and patients (which requires early identification). In this study, clinical data available within 24 hours of admission from an electronic medical record system were used to develop statistical models to predict hospital costs. In this retrospective analysis of clinical data and diagnosis-related groups (DRGs), study subjects were 2,355 patients admitted for at least 1 day to the medicine service at an urban teaching hospital with sophisticated electronic medical records. Of these 2,355 patients, 1,663 (71%) had one of the 41 most common DRGs. Predictive models were derived on a random subset of two thirds of the patients and were validated on the remaining third. The following patient data were obtained: admission and prior diagnostic test results, diagnoses, vital signs; demographic data; prior inpatient and outpatient visits; tests and treatments ordered within 24 hours of admission (discretionary data); DRGs; and total inpatient costs (estimated from charges). Diagnosis-related groups explained 24% of the variance in total costs in the derivation patient set and 16% in the validation set. When only nondiscretionary data were used, the models retained only clinical laboratory results and prior diagnoses, explaining 20% of the derivation set variance in total costs and 16% in the validation set. Adding DRGs increased the variance explained in the derivation set to 34%, but decreased to 24% in the validation set. Adding discretionary data substantially increased the explained variance in the derivation and validation patient sets. The models' median predicted costs underestimated true costs by 10% to 13%, with the lowest error in the models using all types of variables. Clinical data gathered during routine clinical care can be used to adjust for case mix and identify high-cost patients early in their hospital stays, when they could be targeted by cost-containment interventions.

Entities:  

Mesh:

Year:  1995        PMID: 7823640     DOI: 10.1097/00005650-199501000-00001

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

1.  Framework for characterizing data and identifying anomalies in health care databases.

Authors:  A M Savage
Journal:  Proc AMIA Symp       Date:  1999

2.  Using computer-based medical records to predict mortality risk for inner-city patients with reactive airways disease.

Authors:  W M Tierney; M D Murray; D L Gaskins; X H Zhou
Journal:  J Am Med Inform Assoc       Date:  1997 Jul-Aug       Impact factor: 4.497

3.  A model to compute the medical cost of patients in intensive care.

Authors:  C Chaix; I Durand-Zaleski; C Alberti; C Brun-Buisson
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 4.  Evaluation of appropriateness of paediatric admission.

Authors:  U Werneke; R MacFaul
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

5.  The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.

Authors:  Christian Brun-Buisson; Françoise Roudot-Thoraval; Emmanuelle Girou; Catherine Grenier-Sennelier; Isabelle Durand-Zaleski
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

6.  Using electronic medical records to predict mortality in primary care patients with heart disease: prognostic power and pathophysiologic implications.

Authors:  W M Tierney; B Y Takesue; D L Vargo; X H Zhou
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

7.  Diagnosis-Related Group Weight and Derived Case Mix Index to Assess the Complexity among Twins.

Authors:  Rikizam M Joya; Lesley Cottrell; Autumn Kiefer; Mark J Polak
Journal:  Am J Perinatol       Date:  2020-12-30       Impact factor: 3.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.